Bégaud, Bernard

Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study

Bruckert, E., Hayem, G., Dejager, S., Yau, C., & Bégaud, B. (2005) · Cardiovascular Drugs and Therapy

Lipoproteins and Cardiovascular HealthPharmacovigilance and Adverse Drug Reactions

Cited by 1,226

Appetite-suppressant drugs and the risk of primary pulmonary hypertension

Abenhaim, L., Moride, Y., Brenot, F., Rich, S., Benichou, J., Kurz, X., Higenbottam, T., Oakley, C., Wouters, E., Aubier, M., et al. (1996) · New England Journal of Medicine

Pulmonary Hypertension Research and TreatmentsPharmacology and Obesity Treatment

Cited by 1,162

Prevalence and prescription patterns of oral glucocorticoids in adults: a retrospective cross-sectional and cohort analysis in France

Bénard-Laribière, A., Pariente, A., Pambrun, E., Bégaud, B., Fardet, L., & Noize, P. (2017) · BMJ Open

Pharmaceutical Practices and Patient OutcomesAdrenal Hormones and Disorders

Cited by 111

Why are benzodiazepines not yet controlled substances?

Moore, N., Pariente, A., & Bégaud, B. (2015) · JAMA Psychiatry

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 62